Arrow Financial’s AngioDynamics ANGO Stock Holding History

Arrow Financial’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-200	Closed	-$1.46K	–	349
2023 Q3	$1.46K	Buy	+200	New	+$1.66K	﹤0.01%	335

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrow Financial's ANGO Position: Q4 2023 in Review

Arrow Financial sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 200 shares — an estimated $1.46K sold.

Arrow Financial first reported a position in ANGO in Q3 2023 and held it in 1 quarter. The position peaked at $1.46K in Q3 2023. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.

Arrow Financial reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
Arrow Financial sold 200 AngioDynamics shares in Q4 2023, an estimated $1.46K.
Arrow Financial first reported a position in AngioDynamics in Q3 2023 and held it in 1 quarter.
Arrow Financial's AngioDynamics position peaked at $1.46K in Q3 2023.
150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.

Based on Arrow Financial's 13F filing for Q4 2023, filed 12 Feb 2024.